SK Bioscience sells stake in US vaccine developer Novavax

SK Bioscience sells stake in US vaccine developer Novavax

SK Bioscience Co., a drug-making arm of South Korea's No. 2 conglomerate SK Group, has sold a stake in Nasdaq-listed vaccine developer Novavax Inc. ...

SK Bioscience start to deliver Novavax COVID-19 vaccine

SK Bioscience start to deliver Novavax COVID-19 vaccine

South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...

SK Bioscience buys 6.5 million Novavax shares for $83.4 million

SK Bioscience buys 6.5 million Novavax shares for $83.4 million

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...

SK Bioscience to sell Novavax COVID-19 vaccine in Thailand, Vietnam

SK Bioscience to sell Novavax COVID-19 vaccine in Thailand, Vietnam

SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, said on Friday it has acquired non-exclusive rights to sell US-based No...

Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay Hanwha in talks to buy five-star hotel Paraspara Seoul Kia's Lego-like PV5 with 16 variants to hit market in July Stray Kids make K-pop history with landmark stadium show in Germany S.Korea’s most prominent business leader returns with all charges cleared
banner